These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2987636)

  • 1. An ACTH 4-9 analog impairs selective attention in man.
    Born J; Fehm-Wolfsdorf G; Schiebe M; Birbaumer N; Fehm HL; Voigt KH
    Life Sci; 1985 Jun; 36(22):2117-25. PubMed ID: 2987636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of ACTH 4-10 on event-related potentials reflecting attention in man.
    Born J; Fehm-Wolfsdorf G; Voigt KH; Fehm HL
    Physiol Behav; 1987; 39(1):83-7. PubMed ID: 3031714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10.
    Born J; Bräuninger W; Fehm-Wolfsdorf G; Voigt KH; Pauschinger P; Fehm HL
    Exp Brain Res; 1987; 67(1):85-92. PubMed ID: 3040455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dishabituating effects of an ACTH 4-9 analog in a vigilance task.
    Born J; Fehm-Wolfsdorf G; Schiebe M; Rockstroh B; Fehm HL; Voigt KH
    Pharmacol Biochem Behav; 1984 Oct; 21(4):513-9. PubMed ID: 6095322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and electrophysiological signs of attention in man.
    Born J; Fehm-Wolfsdorf G; Lutzenberger W; Voigt KH; Fehm HL
    Peptides; 1986; 7(2):189-93. PubMed ID: 3737444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropin widens the focus of attention in humans. A nonliner electroencephalographic analysis.
    Mölle M; Albrecht C; Marshall L; Fehm HL; Born J
    Psychosom Med; 1997; 59(5):497-502. PubMed ID: 9316182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH and attention in humans: a review.
    Born J; Fehm HL; Voigt KH
    Neuropsychobiology; 1986; 15(3-4):165-86. PubMed ID: 3024062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of ACTH 4-10 effects on human attention.
    Born J; Unseld U; Pietrowsky R; Bickel U; Voigt K; Fehm HL
    Neuroendocrinology; 1990 Aug; 52(2):169-74. PubMed ID: 2177158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R; Mölle M; Fehm HL; Born J
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotropin releasing hormone on human brain function: an analysis based on auditory evoked potentials.
    Fehm HL; Born J
    Horm Metab Res Suppl; 1987; 16():75-9. PubMed ID: 2832298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans.
    Born J; Kern W; Pietrowsky R; Sittig W; Fehm HL
    Psychopharmacology (Berl); 1989; 99(4):439-44. PubMed ID: 2556725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP).
    Born J; Bathelt B; Pietrowsky R; Pauschinger P; Fehm HL
    Psychopharmacology (Berl); 1990; 101(1):34-8. PubMed ID: 2160665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an ACTH 4-9 analog on auditory evoked brainstem responses and middle latency responses.
    Born J; Fehm-Wolfsdorf G; Nagel DJ; Voigt KH; Fehm HL
    Pharmacol Biochem Behav; 1985 Sep; 23(3):367-72. PubMed ID: 2996028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an ACTH 4-9 analog on human cortical evoked potentials in a constant foreperiod reaction time paradigm.
    Rockstroh B; Elbert T; Lutzenberger W; Birbaumer N; Fehm HL; Voigt KH
    Psychoneuroendocrinology; 1981 Dec; 6(4):301-10. PubMed ID: 6275437
    [No Abstract]   [Full Text] [Related]  

  • 15. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R; Perras B; Molle M; Fehm HL; Born J
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an ACTH 4-9 analog on human cortical evoked potentials in a two-stimulus reaction time paradigm.
    Fehm-Wolfsdorf G; Elbert T; Lutzenberger W; Rockstroh B; Birbaumer N; Fehm HL
    Psychoneuroendocrinology; 1981 Dec; 6(4):311-20. PubMed ID: 6119722
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the possible central effects in man of a neuropeptide (ACTH 4-9 analogue).
    Nicholson AN; Stone BM; Jones SJ
    Eur J Clin Pharmacol; 1984; 27(5):561-5. PubMed ID: 6097457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent influences on ERP indicators of attention after neuropeptide ACTH 4-10.
    Born J; Fehm-Wolfsdorf G; Pauschinger P; Fehm HL
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 40():509-13. PubMed ID: 2826106
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSH/ACTH 4-10 influences behavioral and physiological measures of attention.
    Sandman CA; George J; McCanne TR; Nolan JD; Kaswan J; Kastin AJ
    J Clin Endocrinol Metab; 1977 May; 44(5):884-91. PubMed ID: 192754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.